Suppr超能文献

伊朗北部产超广谱β-内酰胺酶(ESBL)和碳青霉烯酶临床分离株中质粒介导的黏菌素和磷霉素耐药性

Plasmid-Mediated Colistin and Fosfomycin Resistance among Clinical Isolates of ESBL- and Carbapenemase-Producing in Northern Iran.

作者信息

Falsafi S, Ghasemian A, Kohansal M, Zarenezhad E, Shokouhi Mostafavi S K, Rezaian M, Bakhtiari A

机构信息

Department of Microbiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Noncommunicable diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.

出版信息

Arch Razi Inst. 2024 Aug 1;79(4):881-888. doi: 10.32592/ARI.2024.79.4.881. eCollection 2024 Aug.

Abstract

The emergence of extensively-resistant strains of () in healthcare settings is linked to prolonged hospitalization and uncontrolled use of antibiotics. There is a paucity of data regarding the prevalence and mechanisms of colistin and fosfomycin resistance encoding genes rate and mechanisms in Iran. The objective of this study was to determine the prevalence of biofilm formation and fosfomycin and colistin resistance among strains producing ESBL and carbapenemases by detecting the , , and genes in Tehran, Iran, during the 2020-2021 period. After collecting 73 samples, the isolates were identified using biochemical tests. Antibiotic susceptibility test was performed using the disk diffusion method. The phenotypic determination of extended-spectrum beta-lactamases (ESBLs) and carbapenemase enzymes was conducted using combined disk and CARBA-NP tests, respectively. The biofilm formation was conducted using a microtiter tissue plate assay. Polymerase chain reaction (PCR) was employed to detect the , and genes,which are associated with colistin and fosfomycin resistance, respectively. The highest resistance rate was observed against ampicillin (97%), chloramphenicol (90%), and ciprofloxacin (87%), respectively.In contrast, the lowest resistance rate was noted against gentamicin (4%), amikacin (10%), and cotrimoxazole (18%). Moreover, 44 and 23 isolates were identified as ESBL and carbapenemase -producing K. pneumonia), respectively. Of the fortyeight isolates that formed strong biofilms,one was a non-biofilm producer. The PCR test revealed the amplification of the gene in four isolates and the genes in one isolate. However, no amplification of the or genes was observed. The present study demonstrated that the frequency of isolates producing ESBL and carbapenemase, as well as , and genes, was relatively low.However,given the potential for these genes to be disseminated more widely, it is imperative to implement effective isolation and control measures. Moreover, these strains demonstrated the capacity to form biofilms in vitro, which can lead to persistent infections in the hospital settings.

摘要

医疗机构中广泛耐药菌株的出现与长期住院和抗生素的无节制使用有关。关于伊朗黏菌素和磷霉素耐药编码基因的流行率及机制的数据匮乏。本研究的目的是通过在2020 - 2021年期间检测伊朗德黑兰产超广谱β-内酰胺酶(ESBL)和碳青霉烯酶的菌株中的mcr、fosA和fosB基因,来确定生物膜形成以及磷霉素和黏菌素耐药性的流行情况。收集73份样本后,通过生化试验鉴定分离株。采用纸片扩散法进行药敏试验。分别使用复合纸片法和CARBA - NP试验进行超广谱β-内酰胺酶(ESBLs)和碳青霉烯酶的表型测定。使用微量滴定组织培养板试验进行生物膜形成检测。采用聚合酶链反应(PCR)检测分别与黏菌素和磷霉素耐药相关的mcr、fosA和fosB基因。观察到对氨苄西林、氯霉素和环丙沙星的耐药率最高,分别为97%、90%和87%。相比之下,对庆大霉素、阿米卡星和复方新诺明的耐药率最低,分别为4%、10%和18%。此外,分别有44株和23株分离株被鉴定为产ESBL和碳青霉烯酶的肺炎克雷伯菌。在形成强生物膜的48株分离株中,有1株不产生生物膜。PCR检测显示4株分离株中mcr基因扩增,1株分离株中fosA基因扩增。然而,未观察到mcr-1或fosB基因的扩增。本研究表明,产ESBL和碳青霉烯酶以及mcr、fosA和fosB基因的菌株频率相对较低。然而,鉴于这些基因有更广泛传播的可能性,实施有效的隔离和控制措施势在必行。此外,这些菌株在体外表现出形成生物膜的能力,这可能导致医院环境中的持续性感染。

相似文献

1
Plasmid-Mediated Colistin and Fosfomycin Resistance among Clinical Isolates of ESBL- and Carbapenemase-Producing in Northern Iran.
Arch Razi Inst. 2024 Aug 1;79(4):881-888. doi: 10.32592/ARI.2024.79.4.881. eCollection 2024 Aug.
2
Colistin resistance in ESBL- and Carbapenemase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Cambodia.
J Glob Antimicrob Resist. 2024 Sep;38:236-244. doi: 10.1016/j.jgar.2024.06.017. Epub 2024 Jul 14.
9
Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
J Infect Public Health. 2022 Aug;15(8):922-929. doi: 10.1016/j.jiph.2022.07.005. Epub 2022 Jul 19.
10
Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China.
Int J Antimicrob Agents. 2015 Jan;45(1):66-70. doi: 10.1016/j.ijantimicag.2014.08.010. Epub 2014 Oct 2.

本文引用的文献

2
Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.
Int J Antimicrob Agents. 2019 Jan;53(1):22-28. doi: 10.1016/j.ijantimicag.2018.09.013. Epub 2018 Sep 27.
3
Colonization, Infection, and the Accessory Genome of .
Front Cell Infect Microbiol. 2018 Jan 22;8:4. doi: 10.3389/fcimb.2018.00004. eCollection 2018.
4
Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli.
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01572-17. Print 2017 Nov.
5
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.
Lancet Infect Dis. 2018 Jan;18(1):37-46. doi: 10.1016/S1473-3099(17)30489-9. Epub 2017 Aug 29.
9
Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan.
Antimicrob Agents Chemother. 2015 May;59(5):2909-13. doi: 10.1128/AAC.04763-14. Epub 2015 Feb 17.
10
Antibiotic Resistance Related to Biofilm Formation in Klebsiella pneumoniae.
Pathogens. 2014 Sep 5;3(3):743-58. doi: 10.3390/pathogens3030743.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验